Degenerative Spondylolisthesis; Micro-decompression vs Decompression + Instrumented Fusion; Long Term Follow up
DS-registry
Less Invasive Decompression Alone as Good as Decompression Plus Instrumented Fusion for Lumbar Spinal Degenerative Spondylolisthesis at Long Term? A Pragmatic Comparative Non-inferiority Observational Study From the Norwegian Registry for Spine Surgery
1 other identifier
interventional
426
1 country
1
Brief Summary
In many countries a majority of patients with degenerative spondylolisthesis are operated on with decompression plus instrumented fusion, but the scientific evidence for adding fusion is controversial. To evaluate whether micro-decompression alone is as good as (non-inferior to) decompression plus instrumented fusion, a study with data from the Norwegian Registry for Spine Surgery was conducted, now the long-term follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
March 5, 2018
CompletedFirst Posted
Study publicly available on registry
March 19, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
ExpectedMarch 12, 2025
March 1, 2025
10.3 years
March 5, 2018
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Responder rate assessed by ODI
The proportion of participants with an improvement on the Oswestry Disability Index score score more than 30% from preoperative to 12 month and long term follow-up.ODI is a self-reported instrument comprising 10 sections where the patient is supposed to mark the most appropriate item.The sum score range from 0 to 100 were 100 represent the greatest impairment.
From date of operation to 12 month follow-up. From date of operation to long-term(7-15 yrs) follow-up
Secondary Outcomes (7)
ODI: Mean change and mean follow-up score
From date of operation to 12 month follow-up and to long term follow-up (7 -15 yrs)
NRS leg pain
From date of operation to 12 month follow-up and long term follow up (7-15 yrs)
NRS back pain
From date of operation to 12 month follow-up and long term follow up (7-15 yrs)
GPE scores
At 12 month follow-up and at long term follow up (7-15yrs)
Hospital stay
Up to 12 months
- +2 more secondary outcomes
Study Arms (2)
Micro-decompression alone
ACTIVE COMPARATORIn Surgical treatment of Degenerative Spondylolisthesis patients are operated on with a midline-precerving decompression without fusion
Decompression and instrumented fusion
ACTIVE COMPARATORIn Surgical treatment of Degenerative Spondylolisthesis patients are operated on with a decompression followed by an instrumental fusion with or without an additional Cage
Interventions
Eligibility Criteria
You may qualify if:
- operated between September 2007 and December 2015 labeled in the registry with both 'Spinal stenosis' and 'Degenerative spondylolisthesis'
- operated on with decompression with or without an additional fusion
You may not qualify if:
- operated with an anterior approach
- had a former operation at index Level
- was labeled with a degenerative scoliose
- was operated in more than 2 Levels
- was operated with non-instrumented fusion
- operated with a standard laminectomy with removing of the posterior midline structures or operated without magnifying devices was excluded from the micro-decompression group
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kysthospitalet i Hagevik, Orthopeadic Clinic, Haukeland University Hospital
Bergen, Hagevik, 5217, Norway
Study Officials
- PRINCIPAL INVESTIGATOR
Ivar Magne Austevoll, PhD
Haukeland University Hosptal
- PRINCIPAL INVESTIGATOR
Eric Loratang Kgomotso, MD
Haukeland University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2018
First Posted
March 19, 2018
Study Start
September 1, 2007
Primary Completion
December 31, 2017
Study Completion (Estimated)
December 31, 2027
Last Updated
March 12, 2025
Record last verified: 2025-03